Article
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus.
BMC infectious diseases - 3 Sept 2018
Soria María Eugenia, Gregori Josep, Chen Qian, García-Cehic Damir, Llorens Meritxell, de Ávila Ana I, Beach Nathan M, Domingo Esteban, Rodríguez-Frías Francisco, Buti María, Esteban Rafael, Esteban Juan Ignacio, Quer Josep, Perales Celia
Abstract excerpt
BACKGROUND: Despite the high sustained virological response rates achieved with current directly-acting antiviral agents (DAAs) against hepatitis C virus (HCV), around 5-10% of treated patients do not respond to current antiviral therapies, and basal resistance to DAAs is increasingly detected among treatment-naïve infected individuals. Identification of amino acid substitutions (including those in minority...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
